S&P 500
7,633.20
+0.31%
Dow Jones
53,893.00
+1.14%
Nasdaq 100
29,106.20
+0.99%
Russell 2000
2,995.41
+0.37%
FTSE 100
10,904.40
+0.20%
Nikkei 225
64,309.90
+1.28%

Investing

BRKR logo Bruker : BRKR

Price Target $49 ↓4.2%
›

BRKR

Stock Data

$52.88

Change up

$1.61 (3.14%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Bruker Corp is a global leader in developing and manufacturing advanced scientific instruments and solutions for a wide range of fields, including life sciences, diagnostics, and material analysis. With a strong focus on innovation, Bruker offers products like mass spectrometry systems, diagnostic kits, and nanotechnology tools. Their portfolio also includes cutting-edge research instruments for studying biological samples and materials at the molecular and atomic levels. Headquartered in Billerica, Massachusetts, Bruker is dedicated to supporting the scientific community with its diverse and technologically advanced offerings.

Latest Activity

Biggest movers · At the close
Gainers
  • PLTRPalantir$162.55+29.4%
  • AAOIApplied Optoelectronics$132.64+20.4%
  • ARMArm$280.61+17.4%
  • FNFabrinet$534.46+17.2%
  • COHRCoherent$330.85+14.8%
Losers
  • BRKRBruker$51.17-20.4%
  • VERXVertex$11.74-12.4%
  • CIFRCipher Mining$21.25-12.1%
  • AMCAMC Entertainment$2.63-7.7%
  • NVONovo Nordisk$44.09-6.4%

Palantir's 29% close pulled the entire AI complex with it, from Arm to the optical names supplying the data centers. Everything outside that trade got sold, with Bruker down 20% and Novo Nordisk sliding again.

Read more
BRKRBruker
Q2 2026
EPS
$0.49
est $0.38+27.5%
Revenue
$839M
est $854M-1.8%

Non-GAAP operating margin jumped to 14.1% from 9.0% a year ago, turning a slight revenue miss into an earnings beat. Scientific Instruments bookings rose organically on semiconductor tools, energy research and biopharma demand, with US academic orders still the weak link. Full-year EPS guidance stands, and management is now pointing to more margin expansion in 2027.

Quarterly EPS — reported vs estimate
Read more
BRKRBruker Corporation
Reports Tue Aug 4Before open6:30 AM ETConfirmed

Bruker reports Q2 before the bell at 6:30 AM ET, and it lands before Thermo Fisher and Agilent investors get their own read on whether biopharma R&D budgets are opening back up. Instrument order trends here set the tone for the whole life science tools group.

    Read more
    BRKRBruker
    New 52-week high$62.91+0.3% vs prior high · 2026-06-03

    Bruker just hit $62.91, its highest price in a year and a fresh 0.33% above the prior peak set last June.

    Read more
    BRKRBRKR
    Regular session
    $60.60
    +9.52%open $55.33

    Bruker's sharp move signals renewed investor appetite for life sciences tools makers after recent sector pressure weighs off.

    Read more

    All Bruker Articles

    19 Articles

    1 2